Trials / Completed
CompletedNCT07120308
To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis
An Investigator-initiated Single-center, Randomized, Double-blind, Placebo-controlled Clinical Study Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
An investigator-initiated single-center, randomized, double-blind, placebo-controlled clinical study .The main purpose is to evaluate the effectiveness of ZKY001 eye drops in treating corneal epithelial defects caused by neurotrophic keratitis in patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZKY001 eye drops | Administer to eyes |
| DRUG | Vehicle (placebo) | Administer to eyes |
Timeline
- Start date
- 2021-09-15
- Primary completion
- 2023-01-30
- Completion
- 2023-01-30
- First posted
- 2025-08-13
- Last updated
- 2025-08-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07120308. Inclusion in this directory is not an endorsement.